Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.

Overview

authors

Friedman, Marissa D

Lacouture, Mario
Dang, Chau

publication date

November 17, 2015

published in

Clinical breast cancer Journal

Research

keywords

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Drug Eruptions

Identity

PubMed Central ID

PMC5599140

Scopus Document Identifier

84950249289

Digital Object Identifier (DOI)

10.1155/2012/351210

PubMed ID

26707653

Additional Document Info

has global citation frequency

7

volume

16

issue

3